Kirsten E. Lyke - Concepedia

Author

Kirsten E. Lyke

Also Known As

Andrew S Ishizuka, Andrew S. Ishizuka, Elizabeth Brown, Florice K Numbi, K E Lyke, K. E. Lyke, K. Lyke, K.E. Lyke, KIRSTEN E. LYKE, Kirsten E. Lyke

157

Publications

13.7K

Citations

H-Index

Concepts

All Affiliations

University of Maryland, Baltimore University of Bamako National Institute of Allergy and Infectious Diseases National Institutes of Health Sanaria

About

Kirsten E. Lyke is an author at University of Maryland, Baltimore specializing in medicine, malaria, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	27	3.3K
2	Public Health	3	3	441
3	Allergy	2	2	162
4	Cell Biology	1	1	13
5	Clinical Immunology	1	1	26

Kirsten E. Lyke

Publications

12.6K

Citations

H-Index

Page 1

	Year	Citations
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates Edward E. Walsh, Robert W. Frenck, Ann R. Falsey, New England Journal of Medicine	2020	2.7K
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults Mark J. Mulligan, Kirsten E. Lyke, Nicholas Kitchin, Nature	2020	1.6K
Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine Robert A. Seder, Lee-Jah Chang, Mary E. Enama, Science Pfspz VaccineMalariaImmunologyImmunodominancePlasmodium Falciparum	2013	768
Homologous and Heterologous Covid-19 Booster Vaccinations Robert L. Atmar, Kirsten E. Lyke, Meagan E. Deming, New England Journal of Medicine	2022	603
Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8 <sup>+</sup> T Cell Immunity Judith E. Epstein, Kavita Tewari, Kirsten E. Lyke, Science MalariaImmunologyImmune RegulationImmunodominanceSuch Protection	2011	533
Serum Levels of the Proinflammatory Cytokines Interleukin-1 Beta (IL-1β), IL-6, IL-8, IL-10, Tumor Necrosis Factor Alpha, and IL-12(p70) in Malian Children with Severe<i>Plasmodium falciparum</i>Malaria and Matched Uncomplicated Malaria or Healthy Controls Kirsten E. Lyke, Robin Burges, Yacouba Cissoko, Infection and Immunity	2004	437
Protection against malaria at 1 year and immune correlates following PfSPZ vaccination Andrew S. Ishizuka, Kirsten E. Lyke, Adam DeZure, Nature Medicine VaccinationPfspz VaccinationVaccine TargetMalariaImmunology	2016	368
A Field Trial to Assess a Blood-Stage Malaria Vaccine Mahamadou A. Théra, Ogobara K. Doumbo, Drissa Coulibaly, New England Journal of Medicine	2011	358
Blood group O protects against severe <i>Plasmodium falciparum</i> malaria through the mechanism of reduced rosetting J. Alexandra Rowe, Ian Handel, Mahamadou A. Théra, Proceedings of the National Academy of Sciences Group OMalariaGenetic EpidemiologyHematologyImmunology	2007	332
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials Martin R. Gaudinski, Katherine V. Houser, Kaitlyn M. Morabito, The Lancet	2017	298

Page 1